Sign in
4

Changes in Ownership

GENELUX Corp Filed Acc 0001209191-23-056455

VP, Clinical Trial Operations sold 18,665 shares at $10.26 ($191,555)

From the SEC's structured data for this filing

Trades in this filing

Yu Yong · VP, Clinical Trial Operations

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-11-21 Sale : show line 1 in the form −18,665 $10.26 $191,555 69,335 D
Open-market sales · 18,665 sh · avg $10.26 · $191,555
Loading xslF345X05/doc4.xml…